Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance.
Mandelboim
Michal
M
Hindiyeh
Musa
M
Meningher
Tal
T
Mendelson
Ella
E
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission* / Q000821:virology*; D008297:Male; D020125:Mutation, Missense; D053139:Oseltamivir / Q000627:therapeutic use*; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D012189:Retrospective Studies; D017423:Sequence Analysis, RNA
D000998:Antiviral Agents; D012367:RNA, Viral; D053139:Oseltamivir
Antiviral Res. 2000 Jul;47(1):1-17
10930642
Curr Pharm Des. 2007;13(34):3531-42
18220789
Nature. 2009 Jun 18;459(7249):931-9
19525932
MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72
19745803